Eton Pharmaceuticals, Inc. Share Price
ETONEton Pharmaceuticals, Inc. Stock Performance
Open $30.46 | Prev. Close $30.39 | Circuit Range N/A |
Day Range $30.46 - $31.63 | Year Range $13.09 - $35.58 | Volume 12,221 |
Average Traded $31.31 |
Eton Pharmaceuticals, Inc. Share Price Chart
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Eton Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $30.46 | $31.01 | +0.00% |
10-Jun-26 | $30.46 | $31.01 | +1.61% |
09-Jun-26 | $30.26 | $30.52 | +1.70% |
08-Jun-26 | $29.58 | $30.01 | +2.99% |
05-Jun-26 | $28.72 | $29.14 | +0.76% |
04-Jun-26 | $27.57 | $28.92 | +4.78% |
03-Jun-26 | $27.20 | $27.60 | +0.84% |